What You Must Do Now to Comply Starting Jan. 1, 2021 Webinar Nov. 19, 2020


WCG FDAnews Logo

WCG FDAnews Logo

BREXIT’s Impact on Medical Devices:

What You Must Do Now to Comply Starting Jan. 1, 2021

An FDAnews Webinar

Thursday, Nov. 19, 2020, 1:30 p.m.-3:00 p.m. EST

https://www.fdanews.com/brexitmd

When the clock strikes Jan. 1, 2021 will one have a plan in place to ensure medical devices can be sold in the UK going forward? Make no mistake: this will require additional effort over and above what one is planning and implementing for the EU Medical Device Regulation (EU-MDR) and In Vitro Diagnostic Regulation (EU-IVDR).

Plan now for these BREXIT-related changes and have an easier path to UK compliance after Jan. 1 and get products to market there faster.

Dan O’Leary, President of Ombu Enterprises, will not only explain the guidance documents, he’ll use change documents to a prior version of the UK regulations to highlight the inevitable issues one must address to sell devices there after BREXIT. Attendees will understand:


  • How the BREXIT transition will impact medical devices
  • The timeline for action
  • The role of the UK Conformity Assessed (UKCA) mark
  • Making sense of the UK conformity assessment bodies
  • The separate rules for Northern Ireland
  • Some of the planned changes in the UK regulations

By understanding the clues to be uncovered in these change documents and what BREXIT means for medical devices, plan for the modifications to come and ensure products will be accepted into the UK market after Jan. 1, 2021.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount

Webinar Details:

BREXIT’s Impact on Medical Devices:

What You Must Do Now to Comply Starting Jan. 1, 2021

An FDAnews Webinar

Thursday, Nov. 19, 2020, 1:30 p.m.-3:00 p.m. EST

https://www.fdanews.com/brexitmd

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/brexitmd

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Leave a Reply